1. The ability of drugs to cause uroporphyria in hepatocytes from 17-day-old chick embryos has been investigated and the response of the cells in culture compared with that of the intact liver of the embryos in ovo. 2. In this chick-embryo system, drugs that cause accumulation of uroporphyrin within 19-24h can only do so in culture; in contrast, 2-allyl-2-isopropylacetamide and 3,5-diethoxycarbonyl-1,4-dihydrocollidine, which stimulate production of protoporphyrin, are effective both in culture and in ovo. 3. A role of exogenous iron in worsening drug-induced uroporphyria was demonstrated in cultures of hepatocytes; iron also caused preferential accumulation of uroporphyrin from added 5-aminolaevulinate in the absence of a porphyrogenic chemical. 4. Uroporphyria was induced in cultures of hepatocytes by drugs of widely different structures, suggesting that the primary molecular target with which they interact may be relatively aspecific in its binding characteristics. 5. These results are briefly discussed, and two alternative hypotheses for the drug-induced effect in uroporphyrinogen metabolism are considered.
Hexachlorobenzene and other polyhalogenated aromatic compounds induce in man and experimental animals a hepatic porphyria (henceforth referred to as 'uroporphyria') characterized by a defect of the liver enzyme uroporphyrinogen decarboxylase and by marked accumulation of uroporphyrin and other highly carboxylated porphyrins [reviewed by Elder (1978) and Smith & De Matteis (1980) ]. The mechanism by which polyhalogenated chemicals induce the enzymic defect is not yet known, but a role for iron is suggested by the observations that, in rodents, concurrent administration of large doses of iron will worsen the metabolic disorder and the underlying enzymic defect (Taljaard et al., 1971; Smith & Francis, 1983) , whereas a condition of iron deficiency will Abbreviations used: ALA, 5-aminolaevulinate; DDC, 3,5-diethoxycarbonyl-1 ,4-dihydrocollidine; DDCOX., oxidized DDC, 3,5-diethoxycarbonylcollidine; AIA, 2-allyl-2-isopropylacetamide; N-MePP, N-methylprotoporphyrin; DMSO afford protection (Sweeney et al., 1979 ). An important step forward in the study of the underlying mechanisms has been the finding (Sinclair & Granick, 1974 ) that chicken-embryo hepatocytes in culture are very sensitive to polyhalogenated hydrocarbons and develop a marked uroporphyria within hours of exposure to the appropriate chemicals, whereas, in the intact rodent, continuous treatment for several days or weeks is usually necessary before a condition of uroporphyria becomes established. The reasons for the marked sensitivity of the chicken hepatocyte system (whether due to some intrinsic property of the chick-embryo liver, to the culture conditions in vitro, or to both) are not yet known. Also, although a defect of the uroporphyrinogen decarboxylase has been documented in chicken hepatocyte cultures treated with polyhalogenated chemicals Swain et al., 1983; De Verneuil et al., 1983a) 16-24h in a humidified incubator at 37°C they were either injected with drugs or used to prepare hepatocytes for culture. Drugs, dissolved in 0.1 ml of DMSO, were injected into the fluids surrounding the embryo through a small hole in the shell and the air sac; the embryos were returned to the incubator for further 24 h before obtaining their liver for porphyrin analyses. Hepatocytes were isolated from finely chopped livers (which had been perfused in situ by injecting 5 ml of ice-cold HBSS through the heart). The livers were treated with collagenase (0.5 mg/ml) in HBSS without Ca2+ and Mg2+; the resulting hepatocytes were counted and, after determining their viability by Trypan Blue exclusion (usually> 90%), they were suspended at a density of 0.9 x 106 cells/ml in Williams E medium containing glutamine (2mM), gentamycin (50ug/ml), insulin (5.7yg/ml), cortisol (4.8 ug/ml) and foetal-calf serum (5%, v/v 
Results

Induction of uroporphyria in chicken hepatocyte cultures by several chemically unrelated drugs
The effect of treating hepatocytes in culture with several drugs on the concentration and composition of the accumulating porphyrins is shown in Table 1 (a). Two groups of chemicals can be distinguished according to whether Uro or Proto is the main porphyrin that accumulates, typical examples of the two groups being AIA and DDC on the one hand, and Aroclor 1254 and Lindane on the other. This difference between drugs in the pattern of porphyrin accumulation that they induce has already been reported by Sinclair & Granick (1974) . Table 1 (a) also shows that drugs which cause accumulation of Uro in chicken hepatocyte cultures are of diverse molecular structure as they include, in addition to Aroclor and Lindane, another halogenated chemical, 1, 1'-(2,2,2-trichloroethylide)bis(4-chlorobenzene) ('DDT') and also several non-halogenated drugs of various molecular size and shape. Among these are phenobarbitone and DDCOX. [see also De Verneuil et al. (1983a) and Marks (1978) ], 2-phenyl-2,2-diethylacetamide, metyrapone, benoxaprofen and 2-propyl-2-isopropylacetamide. It will be noted that although an increase in Uro was observed with all these chemicals, a considerable variation in potency was nevertheless found between them; some, for example 2-propyl-2-isopropylacetamide, being only moderately active.
The activity of uroporphyrinogen decarboxylase was studied by the indirect method of Sinclair et al. (1983) advantage of being simpler to perform and, according to Sinclair et al. (1983) Table 2 . Effect ofAIA, DDC, DDCOX and Aroclor (given on their own or in combination) on the liver porphyrin content ofthe intact chick embryo in ovo Embryos (17 days of age) were treated as indicated in the Experimental section and their liver porphyrins determined 24h later by the fluorimetric technique of Grandchamp et al. (1980) and related to the liver protein content. Results are given as averages ( ± S.E.M.) for the number of observations given in parentheses. *P < 0.05; **P < 0.02, when compared with corresponding value obtained with DDC alone. (De Matteis, 1973; De Matteis & Gibbs, 1975) .
Role of iron in uroporphyria
A role of iron in cultured hepatocytes had been suggested by previous findings that desferrioxamine, an iron chelator, could reduce the block at the uroporphyrinogen decarboxylase (Sinclair & Granick, 1974; De Verneuil et al., 1983a) , but attempts to demonstrate in cell cultures a direct potentiation effect of exogenous iron had not been successful. We now confirm the protective effect of desferrioxamine and also find that when iron is added to cultures in a form that can be readily taken up by cells (White & Jacobs, 1978; Shedlofsky et al., 1983) Smith & Francis (1983) in chronic-administration experiments involving intact rodents. Therefore a direct cellular effect of iron appears to be involved.
An unexpected finding was the ability of desferrioxamine and iron to produce changes in Uro accumulation from added ALA in the absence of a porphyrogenic chemical (Table 4 ). The most pronounced changes observed after desferrioxamine and iron concerned the amounts of Proto accumulating from exogenous ALA, which were markedly increased and decreased respectively. Desferrioxamine also caused a significant decrease in Uro accumulating from added ALA, not only as a percentage of total porphyrins (as might have been expected; Sinclair & Granick, 1975) , but also in absolute amounts, an effect confirmed by measuring Uro and heptacarboxylate porphyrin by h.p.l.c. In contrast, Fe caused a preferential accumulation of Uro from added ALA, but the effects of Fe were less consistent; in most experiments, like the one described in Table 4 , Uro increased both as a percentage of total porphyrins and in absolute amount, in others a similar percentage increase was seen, but the actual amount of Uro remained unchanged. These effects of Fe, as well as the potentiation of drug-induced uroporphyria, could not be reproduced by equivalent amounts of sodium nitrilotriacetate.
Discussion
The present work has confirmed the marked sensitivity of chicken hepatocytes to drugs that induce accumulation of Uro and also shown that Vol. 224 (De Matteis & Gibbs, 1975; Maxwell & Meyer, 1978) . However, they cannot elicit in ovo their primary effect on uroporphyrinogen decarboxylation, which is such a characteristic feature of their effect in culture. We conclude that either the mechanism involved in the specific defect of uroporphyrinogen metabolism is activated in culture, or alternatively, that the liver cell possesses in ovo a protective mechanism against this effect of drugs that is then lost on culturing.
The mechanism by which the characteristic block in uroporphyrinogen metabolism is produced is still obscure. There is evidence from the related drug-induced uroporphyria of the rat that although the catalytic activity of uroporphyrinogen decarboxylase is markedly impaired, the concentration of immunoreactive enzyme remains unchanged (Elder & Sheppard, 1982) . A direct inhibitory effect of polychlorinated biphenyls on the activity of uroporphyrinogen decarboxylase has been demonstrated in vitro at relatively high concentrations (Kawanishi et al., 1981) . However, further studies on the purified enzyme and in intact cells suggest that, at the dose levels which are effective in vivo, the porphyrogenic chemicals are not themselves inhibitory, but interact with enzymic systems in the liver to generate an active inhibitor (De Verneuil et al. 1983a,b) . The latter has been postulated to be a metabolite of the polyhalogenated compounds (Sinclair & Granick, 1974; Debets et al., 1980; Swain et al., 1983; De Verneuil et al., 1983a; Cantoni et al., 1984) , sufficiently reactive to become covalently bound to thiol groups at the enzyme active centre (Debets et al., 1980) . This hypothesis will explain why phenobarbitone, an inducer of cytochrome P-450, increases the inhibition of uroporphyrinogen decarboxylase due to 2,3,7,8-tetrachlorodibenzo-pdioxin (by producing more of the inhibitory metabolites; De Verneuil et al., 1983a), but does not readily explain why phenobarbitone itself is inhibitory. It is in fact difficult to visualize a reactive metabolite common to the various chemicals now shown to be active and to postulate a mechanism by which iron will facilitate its production, as previously suggested (Sinclair & Granick, 1974) . Nevertheless, the active-metabolite hypothesis has attractive features and should be further explored.
An alternative hypothesis that we favour at present is that drugs may cause the metabolic block Metyrapone added (pg/mi of culture) Fig. 2 indirectly, by stimulating production of reactive species, for example, peroxides and free radicals (De Matteis & Stonard, 1977; Sweeney, 1982 and inhibit the decarboxylation reaction (Smith & Francis, 1981) . The synergistic role of iron on the uroporphyrinogen decarboxylase could then result
Vol. 224 from the ability of ferrous iron to participate in peroxidative and free-radical reactions (Crichton, 1979) . A metabolic pathway that gives rise in the liver to superoxide radical and hydrogen peroxide and which can be stimulated by lipid-soluble drugs is the microsomal electron-transport chain (containing the NADPH :cytochrome P-450 reductasecytochrome P-450 complex; White & Coon, 1980) . Reactive oxygen species are produced particularly when the electron transport becomes uncoupled from the mono-oxygenation function ofcytochrome P-450, as found with drugs that bind the cytochrome effectively but cannot be readily metabolized (Ullrich & Diehl, 1971) . Whether this pathway is involved in the induction of uroporphyria by drugs remains to be determined. The present work has also shown that iron can cause preferential accumulation of Uro from added ALA in the absence of an exogenous chemical. This effect cannot yet be interpreted unequivocally, as iron also caused a marked decrease in total porphyrin concentration. Nevertheless this finding may be relevant to the observation that iron can also worsen the course of human uroporphyria in cases where no exposure to chlorinated chemicals is involved but a history of hepatitis is found (Kushneret al., 1975) . Perhaps in the damaged liver of certain individuals a free radical (or peroxide-producing) mechanism becomes activated in the absence of a porphyrogenic drug, and this can then likewise interact with iron to produce a defect in uroporphyrinogen metabolism.
